Back to Agenda
Session 2: Regulatory Dynamics and Future Vision across the Region
Session Chair(s)
Peter J. Pitts
President, Center for Medicine in the Public Interest (CMPI), United States
Rasha Ziada
EDA Chairman Assistant for Technical Development & Capacity Building Affairs, EDA, Egypt
During this session, we will discuss the region’s regulatory dynamics and future trends. The regulatory environment has been fast evolving in the past few years, with a great number of changes across region. The Health Authorities (HAs) are looking into reforms and to adapting to the recent novelties in regulatory affairs, accelerated pathways, variation guidance, roadmaps and digitalisation. In this session, the region’s HAs will be providing their insights, present and future vision, through a brief presentation followed by an interactive Panel Discussion with Q&A.
Speaker(s)
Sabah Memon
Senior Pharmacist, National Health Regulatory Authority (NHRA), Bahrain
Hajed M.H Hashan
Deputy of General Director, Gulf Health Council, Saudi Arabia
Wesal Al Haqish
Drug Directorate Director, Jordan Food and Drug Administration (JFDA), Jordan
Sarah Al Maqseed
Registration and Release Superintendent, Ministry of Health, Kuwait, Kuwait
Dr. Mohammed Hamdan Al Rubaie, PHD, MSC
Directorate General of Pharmaceutical Affairs and Drug Control, Ministry of Health, Oman
Adel A. Al Harf, PHD
Executive Vice President for Drug Sector, Saudi Food and Drug Authority (SFDA), Saudi Arabia
Have an account?